Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Operating Income (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Operating Income for 13 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income rose 1525.09% year-over-year to $8.3 million, compared with a TTM value of -$187.3 million through Dec 2025, down 88.91%, and an annual FY2025 reading of -$187.3 million, down 88.91% over the prior year.
  • Operating Income was $8.3 million for Q4 2025 at Tandem Diabetes Care, up from -$22.9 million in the prior quarter.
  • Across five years, Operating Income topped out at $12.7 million in Q4 2021 and bottomed at -$127.8 million in Q1 2023.
  • Average Operating Income over 5 years is -$29.5 million, with a median of -$24.5 million recorded in 2024.
  • The sharpest move saw Operating Income plummeted 733.34% in 2023, then skyrocketed 1525.09% in 2025.
  • Year by year, Operating Income stood at $12.7 million in 2021, then crashed by 239.56% to -$17.8 million in 2022, then tumbled by 97.22% to -$35.1 million in 2023, then soared by 98.34% to -$582000.0 in 2024, then soared by 1525.09% to $8.3 million in 2025.
  • Business Quant data shows Operating Income for TNDM at $8.3 million in Q4 2025, -$22.9 million in Q3 2025, and -$51.8 million in Q2 2025.